Page 77 - Ethical Guidelines for Conducting Research Studies Involving Human Subjects

❑ Research involving the directed donation of stem cell lines
or, other human cells or cell lines of a pluripotent nature to
particular individuals, unless the research involves autologous
donation.

❑ Research in which human or non-human ES cells, EG cells,
iPS cells, or other cells that are likely to be pluripotent are
combined with a human embryo.

❑ Research in which human or non-human ES cells, EG cells,
iPS cells, or other cells that are likely to be pluripotent are grafted
to a human fetus.

❑ Research in which human ES cells, EG cells, iPS cells, or
other cells that are likely to be pluripotent are combined with a
non-human embryo.

❑ Research in which human ES cells, EG cells, iPS cells, or
other cells that are likely to be pluripotent are grafted to a non-
human fetus. (CIHR, 2010, Canada)

❑ Any in-vitro culture of intact human embryo, or any
organized cellular structures that have the potential of developing
into human organs and tissues, regardless of the method of its
derivation, beyond 6 days.

❑ Clinical trials using cells after major manipulation or those
sponsored by multinationals involving stem cell products imported
from abroad.

BMRC also follow guidelines of “Guidelines for the Conduct of Human
Embryonic Stem Cell Research” by ISSCR, 2006, “Guidelines for Stem Cell
Research” ICMR, 2012 and NEGHR, Philippine wherever required in
respect to consider religious, social and cultural norms, values as well as if
the law permits.

BMRC ETHICAL GUIDELINE ON HUMAN SUBJECTS Page 73